Found: 10
Select item for more details and to access through your institution.
Preclinical childhood sarcoma models: drug efficacy biomarker identification and validation.
- Published in:
- Frontiers in Oncology, 2015, p. 1, doi. 10.3389/fonc.2015.00193
- By:
- Publication type:
- Article
Evaluation of patritumab with or without erlotinib in combination with standard cytotoxic agents against pediatric sarcoma xenograft models.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Initial testing (stage 1) of M6620 (formerly VX-970), a novel ATR inhibitor, alone and combined with cisplatin and melphalan, by the Pediatric Preclinical Testing Program.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Initial testing (stage 1) of the curaxin CBL0137 by the pediatric preclinical testing program.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Initial testing (stage 1) of tazemetostat (EPZ-6438), a novel EZH2 inhibitor, by the Pediatric Preclinical Testing Program.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Characterization of MHC Class I and β-2-Microglobulin Expression in Pediatric Solid Malignancies to Guide Selection of Immune-Based Therapeutic Trials.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Initial Testing of NSC 750854, a Novel Purine Analog, Against Pediatric Tumor Models by the Pediatric Preclinical Testing Program.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Genomic profiling of subcutaneous patient-derived xenografts reveals immune constraints on tumor evolution in childhood solid cancer.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-43373-1
- By:
- Publication type:
- Article
Synergistic Antitumor Activity of Talazoparib and Temozolomide in Malignant Rhabdoid Tumors.
- Published in:
- Cancers, 2024, v. 16, n. 11, p. 2041, doi. 10.3390/cancers16112041
- By:
- Publication type:
- Article
Defining function of wild-type and three patient-specific TP53 mutations in a zebrafish model of embryonal rhabdomyosarcoma.
- Published in:
- eLife, 2023, p. 1, doi. 10.7554/eLife.68221
- By:
- Publication type:
- Article